Return to homepagePandemic Pact

Molecular design, synthesis and screening for anti-coronaviral activity of heterocyclic compounds with controllable cell toxicity via nanoconfinement (COVIDAvir)

  • Funded by Bulgaria National Science Fund (BNSF), National Natural Science Foundation of China (NSFC)
  • Total publications:0 publications

Grant number: 8201101434

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Funder

    Bulgaria National Science Fund (BNSF), National Natural Science Foundation of China (NSFC)

  • Principal Investigator

    Manli Wang, Meglena Kandinska-Vasileva

  • Research Location

    China, United States of America

  • Lead Research Institution

    Wuhan Institute of Virology, Chinese Academy of Sciences, Sofia University

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract